A Phase 1/2 Study of Pixantrone, Etoposide, Bendamustine And, in Cd20+ Tumors, Rituximab in Patients With Relapsed Aggressive B- Or T-Cell Lymphomas-The P[r]eben Study
Hematological Oncology - United Kingdom
doi 10.1002/hon.2440_7
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
Wiley